ELAFIBRANOR Pharmacologic Class Indexing

Class set ID
f56cb11a-1299-4dbb-9f83-ecdde63bed69
Version
1
Effective date
20250205
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use IQIRVO® safely and effectively. See full prescribing information for IQIRVO. IQIRVO (elafibranor) tablets, for oral use Initial U.S. Approval: 2024Ipsen Biopharmaceuticals, Inc. | PCAS | Lab-Service SAS | Quinta-Analytica s.r.o. | PCAS Finland Oy | Delpharm Milano Srl202406103